← Back to Search

Behavioral Intervention

GetActive+ Program for Chronic Pain (iHOPE Trial)

N/A
Waitlist Available
Led By Ana-Maria Vranceanu, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to complete the 6-minute walk test under supervision of study staff
Pain score >=4 (moderate) on the Numerical Rating Scale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention, 6-month follow up (~9 months total)
Awards & highlights

iHOPE Trial Summary

This trial tests a program combining mind-body and walking activities to improve physical and emotional function in 200 people. Measures are taken before, during, and after the program.

Who is the study for?
This trial is for older adults (age >=55) with chronic musculoskeletal pain who can communicate in English or Spanish, are mentally able to participate, and can do a supervised walk test. They must not have untreated psychosis or substance issues, serious illnesses expected to worsen soon, or be unwilling to wear an activity tracking device.Check my eligibility
What is being tested?
The study compares a 10-week mind-body and walking program called GetActive+ against usual treatment. It measures improvements in physical and emotional function using self-reports, performance tests like the six-minute walk test, step counts, and checks how well the program works and if it's accepted by participants.See study design
What are the potential side effects?
Since this trial involves a non-drug intervention focusing on mind-body exercises and walking programs rather than medication or medical procedures, side effects may include typical exercise-related risks such as muscle strain but are generally minimal.

iHOPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk for 6 minutes under supervision.
Select...
My pain level is moderate or higher.
Select...
I can think and understand well enough to take part in the study.
Select...
I am 55 years old or older.
Select...
I have had chronic pain in my muscles or bones for more than 3 months.

iHOPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention, 6-month follow up (~9 months total)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention, 6-month follow up (~9 months total) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical function self-report
Secondary outcome measures
Acceptability of Intervention Sessions
Adoption of Intervention
Anxiety
+9 more
Other outcome measures
Current Status
Discrimination
Emotional Function
+12 more

iHOPE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GetActive+Experimental Treatment1 Intervention
A mind-body program focused on increasing physical and emotional function in older adults with chronic musculoskeletal pain
Group II: Treatment as usualActive Control1 Intervention
Treatment as Usual (TAU) includes traditional primary care management of chronic pain.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,936 Previous Clinical Trials
13,198,521 Total Patients Enrolled
30 Trials studying Chronic Pain
4,813 Patients Enrolled for Chronic Pain
Ana-Maria Vranceanu, PhDPrincipal InvestigatorMassachusetts General Hospital
20 Previous Clinical Trials
1,886 Total Patients Enrolled
5 Trials studying Chronic Pain
484 Patients Enrolled for Chronic Pain
Christine Ritchie, MD, MPHPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for participants in this experiment?

"According to the latest data on clinicaltrials.gov, this particular trial is not currently recruiting participants; however, it was posted September 1st 2024 and updated November 1st 2023. There are 451 other medical studies that have open enrollment right now."

Answered by AI
~133 spots leftby Apr 2027